Lifeboat Foundation

The humble membranes that enclose our cells have a surprising superpower: They can push away nano-sized molecules that happen to approach them. A team including scientists at the National Institute of Standards and Technology (NIST) has figured out why, by using artificial membranes that mimic the behavior of natural ones. Their discovery could make a difference in how we design the many drug treatments that target our cells.

The team’s findings, which appear in the Journal of the American Chemical Society, confirm that the powerful electrical fields that cell membranes generate are largely responsible for repelling nanoscale particles from the surface of the cell.

This repulsion notably affects neutral, uncharged nanoparticles, in part because the smaller, charged molecules the electric field attracts crowd the membrane and push away the larger particles. Since many drug treatments are built around proteins and other nanoscale particles that target the membrane, the repulsion could play a role in the treatments’ effectiveness.

Summary: Researchers identified cortical gray matter thinning as a potential early biomarker for dementia. In a study involving 1,500 participants from diverse backgrounds, thinner cortical gray matter was linked to a higher risk of developing dementia 5 to 10 years before symptoms appeared.

This finding suggests that measuring gray matter thickness via MRI could be key in early dementia detection and intervention. The research highlights the importance of early diagnosis in managing and possibly slowing the progression of dementia.

Scientists have cleared a significant hurdle in the years-long effort to save Africa’s northern white rhinoceros from extinction with the first-ever rhino pregnancy using in vitro fertilization.

A new medical breakthrough with embryo transfer offers hope for Africa’s northern white rhinos—there are only two left.

People with long COVID have dysfunctional immune cells that show signs of chronic inflammation and faulty movement into organs, among other unusual activity, according to a new study by scientists at Gladstone Institutes and UC San Francisco (UCSF).

The team analyzed immune cells and hundreds of different immune molecules in the blood of 43 people with and without long COVID. They delved particularly deep into the characteristics of each person’s T cells—immune cells that help fight viral infections but can also trigger chronic inflammatory diseases.

Their findings, which appear in Nature Immunology, support the hypothesis that long COVID may involve a low-level viral persistence. The study also reveals a mismatch between the activity of T cells and other components of the immune system in people with long-term COVID-19.

In a recent study published in JAMA Neurology a group of researchers determined the utility of a novel and commercially available immunoassay for plasma phosphorylated tau 217 (p-tau217) to detect Alzheimer’s Disease (AD) pathology and evaluate reference ranges for abnormal amyloid β (Aβ) and longitudinal change across three selected cohorts.

Blood biomarkers have become key in AD diagnosis, offering a more scalable option than cerebrospinal fluid (CSF) or positron emission tomography (PET) scans. They are particularly beneficial in settings with limited access to advanced testing, paving the way for early and precise diagnosis and better patient management. p-tau, especially p-tau at threonine 217 (p-tau217), stands out as a leading blood biomarker. It excels in differentiating AD from other conditions and detecting AD in mild cognitive impairment cases, often outperforming other tau biomarkers.

As the medical community moves towards anti-Aβ therapies for dementia, validated blood biomarkers like p-tau217 are crucial for guiding treatment. Further research is necessary to validate plasma p-tau217 across diverse memory clinic populations, addressing comorbidities to enhance its clinical utility for AD.

Heart tumor or cardiac tumor is a rare condition that is prevalent in adults. Though the exact cause is unknown, genetics could play a role.

Advanced Science is a high-impact, interdisciplinary science journal covering materials science, physics, chemistry, medical and life sciences, and engineering.

Eleven astronauts and cosmonauts from around the world are living and working together aboard the International Space Station (ISS) today, January 22. The four Axiom Mission 3 (Ax-3) private astronauts met the seven Expedition 70 crew members on Saturday beginning two weeks of dual operations.

The Ax-3 crew spent the weekend getting familiar with space station systems and emergency procedures before starting Monday with a full schedule of science and media activities. Ax-3 Commander Michael López-Alegría joined Pilot Walter Villadei and studied how microgravity affects the biochemistry of neurodegenerative diseases such as Alzheimer’s to improve health on Earth and in space. The duo later inserted samples into a fluorescence microscope for a study seeking to prevent and predict cancer diseases to protect crews in space and humans on Earth.

Year 2018 Age related symptoms may be even more simple to reverse by recharging the mitochondria then eventually we can have genetically engineered mitochondria to run longer so the cycles of the human body could run indefinitely.

Singh, B., Schoeb, T.R., Bajpai, P. et al. Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function. Cell Death Dis 9, 735 (2018). https://doi.org/10.1038/s41419-018-0765-9

Download citation.